On-Demand Videos

Millions of women each year are affected by vaginitis infections, and they are at increased risk for sexually transmitted infections (STIs). STI rates continue to be on the rise in the U.S. and the impact of STIs can be detrimental to women’s health. Accurate clinical diagnosis of vaginitis and STIs can help reverse this trend. Watch Dr. Arlene Seña, and Dr. Jane Schwebke in a discussion on STI co-infections and vaginitis. The discussion will review recently published literature and study data that highlights STI distribution among women with symptoms of vaginitis, single and multiple infection rates in women with vaginitis, and STI prevalence of women with clinician and lab diagnosed bacterial vaginosis. The impact of misdiagnosis will be examined as well as the accuracy of vaginitis diagnosis with molecular diagnostics. Learn about Dr. Arlene Seña and Dr. Jane Schwebke. Disclaimer: Hologic, Inc. sponsored this webinar, which was planned and hosted by IDSOG. Views and opinions expressed in this video are those of the speakers and do not necessarily represent the views or opinions of Hologic, Inc.

This webinar, hosted by NCSD and sponsored by Hologic, highlights an overview of recent climate/impact on the trans and non-binary community, reviews implementing trauma-informed practices and why language matters in testing, and emphasizes the importance of accessibility and inclusivity of testing. Dr. Aniruddha (Anu) Hazra highlights his work at University of Chicago and Howard Brown Health, the largest LGBTQ+ health provider in the Midwest, and Taryn Norman (she/her) discusses their work as the Executive Director at HOPE Testing in Tulsa, OK. Learn about Dr. Hazra and Taryn Norman. Disclaimer: Hologic, Inc. sponsored this webinar, which was planned and hosted by NCSD. Views and opinions expressed in this video are those of the speakers and do not necessarily represent the views or opinions of Hologic, Inc.

Hosted by The National Coalition of STD Directors (NCSD), this webinar will highlight an overview of vaginitis, prevalence in the U.S., clinical manifestations, case studies, co-infections with other STIs, and the importance of accurate NAAT testing. Learn more about Dr. Jane Schwebke and Dr. Kyle Bukowski Disclaimer: Hologic, Inc. sponsored this webinar, which was planned and hosted by NCSD. Dr. Jane Schwebke is a paid consultant of Hologic, Inc. and Dr. Kyle Bukowski is an employee of Hologic, Inc.  Views and opinions expressed in this video are those of the speakers and do not necessarily represent the views or opinions of Hologic, Inc.

In this presentation, Kyle Bukowski, MD, FACOG, provides an in-depth overview of common causes, challenges, and risks associated with vaginitis. Dr. Bukowski further discusses methodologies and treatment guidelines for healthcare providers seeking to provide optimal patient care through an enhanced understanding of vaginitis management. Learn more about Dr. Kyle Bukowski.

The National Coalition of STD Directors (NCSD), this webinar, Emergence of Mycoplasma genitalium as a Clinically Important Sexually Transmitted Infection*, highlights the key clinical manifestations of Mycoplasma genitalium (M. gen) infection, discuss current epidemiology and resistance concerns of M. gen infection in the U.S., review M. gen diagnostic approaches and testing recommendations, and discuss the management of M. gen infection. Learn more about Dr. Geisler and Dr. Munson *Hologic sponsored this webinar, which was planned and hosted by NCSD.  Views and opinions expressed in this video are those of the speakers and do not represent the views or opinions of Hologic, Inc., or the intended uses of the Hologic assays.  

Dr. Melissa Martinez-Adorno, an award-winning Obstetrician Gynecologist, discusses current CDC guidelines on clinical practices in the U.S. for Mycoplasma genitalium and reviews case studies that highlight how to improve patient care through established screening guidelines. Learn more about Dr. Melissa Martinez-Adorno.

Dr. Tonya Chaffee, Clinical Professor, Pediatrics UCSF, discusses the increasing rate of Sexually Transmitted Infections (STI) in the U.S. population and reviews case studies that highlight how to address STIs in young people. She also educates on the importance of Opt-Out screening as the most effective strategy to reduce STI prevalence in this on-demand webinar. Learn more about Dr. Tonya Chaffee.

During this presentation, Dr. Salika Shakir, PhD D(ABMM), will discuss vaginitis, a leading reason for OB/GYN visits.1,2 Upon completion of this program, attendees will be able to: Define vaginitis and its associated health consequences Describe the common causes of vaginitis including bacterial vaginosis, candida vaginitis and Trichomonas vaginalis Compare the typical methods for diagnosing vaginitis including wet prep, Amsel, gram stain with Nugent, direct probe, yeast culture and nucleic acid amplification testing (NAAT) Explain the reasons for using NAAT to diagnose vaginitis Outline the treatment options for the common causes of vaginitis Dr. Shakir was paid an honorarium by Hologic, Inc.  Views and opinions expressed in this video are those of the speakers and do not necessarily represent the views or opinions of Hologic, Inc.   Kent HL. Epidemiology of Vaginitis. Am J Obstet Gynecol. 1991 Oct;165(4 Pt 2):1168-76. ACOG Vaginitis Frequently Asked Questions.  Updated September 2023.  Accessed January 24, 2024. 

Millions of women each year are affected by vaginitis infections, and they are at increased risk for sexually transmitted infections (STIs). Join Dr. Jane Schwebke in a discussion on co-infection with STIs and vaginitis. The discussion will review recently published literature and study data that highlights STI distribution among women with symptoms of vaginitis, single and multiple infection rates in women with vaginitis, and STI prevalence of women with clinician and lab diagnosed bacterial vaginosis. The impact of misdiagnosis will be examined as well as the accuracy of vaginitis diagnosis with molecular diagnostics. Learn more about Dr. Jane Schwebke. Dr. Schwebke is a paid consultant of Hologic.  Views and opinions expressed in this video are those of the speaker and do not necessarily represent the views or opinions of Hologic, Inc.

In observance of Sexual Health Month, the Infectious Disease Society of America Foundation (IDSAF) hosted a webinar to a discuss Mycoplasma genitalium (M. gen) – the next installment in their Dr. John G. Bartlett Memorial Education Series. Two specialists in the areas of infectious diseases and obstetrics and gynecology explored the various aspects of M. gen, including its epidemiology, testing methods and treatment options. Our experts provided valuable insights into M. gen, its health implications and the measures we can take to address this under-recognized STI. Learning Objectives: Explore the impact of M. gen on sexual health. Assess the epidemiology of M. gen and identify individuals who are at a higher risk of contracting the infection and complications associated with untreated M. gen infections. Examine the testing methods currently available for the detection of M. gen. Describe the treatment options that exist for M. gen infections and investigate the emergence of drug-resistant strains of M. gen and its implications. Review preventive measures and safe sexual practices that individuals can adopt to reduce the risk of M. gen infections. Hologic sponsored this webinar, which was planned and hosted by IDSAF.  Dr. Irene Stafford is a paid consultant of Hologic.  Views and opinions expressed in this video are those of the speakers and do not necessarily represent the views or opinions of Hologic, Inc.

Watch Drs. Tonya Chaffee and Irene Stafford discuss the increasing rate of Sexually Transmitted Infections (STI) in the U.S. population. The following topics will be addressed: the importance of opt-out screening as the most effective strategy to reduce STI prevalence in chlamydia and gonorrhea and real-world data reflective of current clinical practices in the U.S. for Mycoplasma genitalium and ways to improve patient care through established testing guidelines. Learn more about Dr. Tonya Chaffee and Dr. Irene Stafford.

During this presentation, Dr. Erik Munson will discuss Mycoplasma genitalium (M. gen), a prevalent and often misdiagnosed STI, will be discussed. Upon completion of this video, viewers will be able to: Describe M. gen and why it is challenging to diagnose Explain the clinical presentation of M. gen and its associated health consequences Summarize the prevalence of M. gen State the CDC guidelines for M. gen testing Outline the treatment options for M. gen depending on the availability of resistance testing Compare RNA and DNA-based tests for M. gen detection Learn more about Dr. Eric Munson

During this presentation, Dr. Erik Munson will discuss Mycoplasma genitalium (M. gen), a prevalent and often misdiagnosed STI, will be discussed. Upon completion of this video, viewers will be able to: Describe M. gen and why it is challenging to diagnose Explain the clinical presentation of M. gen and its associated health consequences Summarize the prevalence of M. gen State the CDC guidelines for M. gen testing Outline the treatment options for M. gen depending on the availability of resistance testing Compare RNA and DNA-based tests for M. gen detection Learn more about Dr. Eric Munson

Mycoplasma genitalium infections present unique challenges from a treatment perspective. Proper diagnosis is important to drive the right treatment decisions. Hear from clinical experts, Dr. William M. Geisler and Dr. Barbara Van Der Pol, as they discuss complex cases of this STI and provide clinical recommendations for treatment options. Learn more about Dr. Damon Getman, Dr. Geisler and Dr. Van Der Pol   

Join Dr. Kyle Bukowski, Chief Medical Officer for Planned Parenthood of Maryland, as he discusses real-world data reflective of current clinical practices in the U.S. for mycoplasma genitalium. He will also address ways in which we can improve patient care through established screening guidelines. Learn more about Dr. Kyle Bukowski.

Join Dr. Jamie Shutter and Dr. Melissa Maxwell-Stropes as they discuss the latest CDC recommendations for Mycoplasma genitalium testing and the importance of utilizing rRNA-based NAAT (Nucleic Acid Amplification Testing). Learn more about Dr. Jamie Shutter and Dr. Melissa Maxwell-Stropes.